national stem-cell therapy logo

REPROCELL USA Launches Advanced GMP Facility for Stem Cell Manufacturing

Help Spread The Word, Share Post:

REPROCELL USA has marked a significant milestone with the inauguration of its state-of-the-art GMP manufacturing facility dedicated to producing high-quality stem cells. This facility, located in Beltsville, Maryland, was officially opened on May 15, 2024, by Mr. Kevin Anderson, Secretary of the Department of Commerce, State of Maryland.

The new facility is designed to manufacture Human Induced Pluripotent Stem Cells (hiPSCs) and Human Mesenchymal Stem Cells (hMSCs), both of which are crucial for therapeutic applications. These cells are produced using the Cytocentric Xvivo system from BioSpherix, a closed GMP cell culturing system that ensures a contamination-free environment by integrating modular closed incubators and hoods. This system offers superior environmental control and monitoring, resulting in more consistent and higher quality stem cell cultures.

REPROCELL employs a proprietary method of footprint-free RNA reprogramming for generating these stem cells. The raw materials undergo stringent selection, ensuring compliance with various geographical regulatory requirements. This advanced technology not only enhances the quality of the cells but also speeds up the production process, providing a competitive edge in the market.

The new GMP facility enables REPROCELL to supply off-the-shelf GMP grade hiPSCs and hMSCs for both internal use and to meet the demands of therapeutic, pharmaceutical, and biotechnology companies. This development positions REPROCELL as a leader in providing high-quality stem cells for clinical applications.

Dr. Chikafumi Yokoyama, CEO of the global REPROCELL group, highlighted the significance of this facility, stating that it provides a unique resource for cell therapy companies in Maryland and across the USA. Rama Modali, CEO of REPROCELL USA, echoed this sentiment, emphasizing the competitive pricing and superior quality of their stem cell products.

About REPROCELL: Founded in 2002 and based in Yokohama, Japan, REPROCELL supports the entire drug discovery pathway with services and reagents. The company’s brands, including BioServe, Stemgent, Alvetex, and Biopta, provide a comprehensive range of products and services for stem cell research and human tissue assays. REPROCELL has laboratories in the USA, UK, and India to support global research efforts.

For more information, visit REPROCELL’s website or call 301-470-3362.

*** All content on is for informational purposes only. All medical questions and concerns should always be consulted with your licensed healthcare provider.

*** Our website contains affiliate advertisements. We may receive a commission for purchases made through these ads at no additional cost to you.

Stay Connected

More Updates